Exagen Inc. SEC filings XGN

Exagen Inc. has 421 filings in SEC EDGAR's recent list, going back to Dec 29, 2003. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 9, 2026
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 10, 2025
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 24, 2023 —
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Apr 28, 2022
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Apr 27, 2021
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Apr 29, 2020

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
XGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Vista, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1274737
Former names
EXAGEN DIAGNOSTICS INC (until May 18, 2017)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.